Endo
Pharmaceuticals is expanding to bring new therapies to
patients, new treatment approaches to physicians and better outcomes
to managed care providers. Today, we're working in pain management,
urology, endocrinology and oncology. We're evaluating new drug
delivery technologies to create innovative new medicines. We're
empowering our commercial team to work with physicians and payers to
become real partners in medical care, not just suppliers. These are
exciting changes which move us closer to our goal of becoming the
premier specialty pharmaceutical company.
HealthTronics, Inc. became a wholly owned subsidiary of Endo Pharmaceuticals on July 15,2010.
HealthTronics, Inc. is a premier urology company providing an exclusive suite of healthcare services and technology, including urologist partnership opportunities, surgical and capital equipment, maintenance services and anatomical pathology services. The company's product portfolio includes a full line of urology equipment and products, including lithotripters, cryoablation products used for the treatment of prostate cancer, surgical lasers for treatment of BPH, and anatomical pathology services. As a service provider, HealthTronics offers the latest technology in lithotripsy services and prostate therapy services, including BPH treatments and prostate cancer treatments. For more information, please visit www.HealthTronics.com.
*By clicking on the link(s) on this page you will leave the Endo.com website and move to an external website(s) independently operated and not managed by Endo Pharmaceuticals. Because Endo Pharmaceuticals does not control the content of the website(s) you are about to visit, and due to its constantly changing nature, we cannot be responsible for its content, accuracy, practices, or standards.
